Fig. 5: Copper-mediated radiolabeling with other radionuclides.

A The copper-mediated radioiodination and radioastination of radiotheranostic PARP inhibitors¹⁰⁶. B The coppermediated radiobromination of a variety of small-molecule radiotheranostic agents¹⁰⁸.